U.S. President Trump has leveled criticism at Goldman Sachs over its allegedly flawed research report on tariff risks. This move has raised concerns among investors and scholars that it may prompt analysts to soften the content of their research, thereby undermining the reliability of information available to investors. Research reports from esteemed banks like Goldman Sachs are typically utilized by institutional investors, such as hedge funds and asset management companies, as a cornerstone for their capital allocation decisions.
